Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Evaluating containment effectiveness of A2 and B2 biological safety cabinets.

Taylor AV, Baker N, Hulsey M, Bennett CC, Meiners M, Gonzales BA.

Am J Health Syst Pharm. 2019 Apr 17;76(9):599-607. doi: 10.1093/ajhp/zxz030.

PMID:
31361829
2.

Validation of cross-contamination control in biological safety cabinet for biotech/pharmaceutical manufacturing process.

Hu SC, Shiue A, Tu JX, Liu HY, Chiu RB.

Environ Sci Pollut Res Int. 2015 Dec;22(23):19264-72. doi: 10.1007/s11356-015-5091-5. Epub 2015 Aug 11.

PMID:
26257118
3.
4.

Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo.

Schierl R, Masini C, Groeneveld S, Fischer E, Böhlandt A, Rosini V, Paolucci D.

J Oncol Pharm Pract. 2016 Feb;22(1):37-45. doi: 10.1177/1078155214551316. Epub 2014 Sep 16.

PMID:
25227229
5.

Improving the biosafety of cell sorting by adaptation of a cell sorting system to a biosafety cabinet.

Lennartz K, Lu M, Flasshove M, Moritz T, Kirstein U.

Cytometry A. 2005 Aug;66(2):119-27.

6.

Mayo Clinic approaches to meet United States Pharmacopeia <797> requirements for facility design and environmental controls of nuclear pharmacy.

Hung JC, Anderson MM.

J Nucl Med. 2009 Jan;50(1):156-64. doi: 10.2967/jnumed.108.054742. Epub 2008 Dec 17.

7.

Biological safety cabinetry.

Kruse RH, Puckett WH, Richardson JH.

Clin Microbiol Rev. 1991 Apr;4(2):207-41. Review.

8.

Effects of outside air temperature on the preparation of antineoplastic drug solutions in biological safety cabinets.

Umemura M, Itoh A, Ando Y, Yamada K, Wakiya Y, Nabeshima T.

J Oncol Pharm Pract. 2015 Aug;21(4):243-8. doi: 10.1177/1078155214530176. Epub 2014 Apr 8.

PMID:
24714128
9.

Flow and performance of an air-curtain biological safety cabinet.

Huang RF, Chou CI.

Ann Occup Hyg. 2009 Jun;53(4):425-40. doi: 10.1093/annhyg/mep020. Epub 2009 Apr 27.

PMID:
19398506
10.

Evaluation of surface contamination with cyclophosphamide following simulated hazardous drug preparation activities using two closed-system products.

Zock MD, Soefje S, Rickabaugh K.

J Oncol Pharm Pract. 2011 Mar;17(1):49-54. doi: 10.1177/1078155210374673. Epub 2010 Jun 28.

11.

Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.

Peters GF, McKeon MR, Weiss WT.

Am J Health Syst Pharm. 2007 Mar 15;64(6):622-31.

PMID:
17353571
12.

Open fronted safety cabinets in ventilated laboratories.

Clark RP, Osborne RW, Pressey DC, Grover F, Keddie JR, Thomas C.

J Appl Bacteriol. 1990 Sep;69(3):338-58.

PMID:
2246141
13.
14.
15.

Class II (laminar flow) biological safety cabinet.

Newsom SW.

J Clin Pathol. 1979 May;32(5):505-13.

16.

Fluid dynamics of cytotoxic safety cabinets.

Braconnier R, Bonthoux F.

Ann Occup Hyg. 2010 Mar;54(2):236-46. doi: 10.1093/annhyg/mep087. Epub 2009 Dec 9.

PMID:
20007340
17.

Microbiological studies on the performance of a laminar airflow biological cabinet.

McDade JJ, Sabel FL, Akers RL, Walker RJ.

Appl Microbiol. 1968 Jul;16(7):1086-92.

19.
20.

Sampling for airborne fluorouracil in a hospital drug preparation area.

McDiarmid MA, Egan T, Furio M, Bonacci M, Watts SR.

Am J Hosp Pharm. 1986 Aug;43(8):1942-5.

PMID:
3752134

Supplemental Content

Support Center